Latest Period
Q2 2026
Security Snapshot
Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) Institutional Ownership
CUSIP: 15673T100
13F Institutional Holders and Ownership History from Q2 2021 to Q2 2026
Institutions Reporting
99
Shares (Excl. Options)
158,001,283
Price
$2.45
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- IPSC on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 158,001,283
- Total 13F value
- $386,982,337
- Portfolio coverage rank
- 0%
- Share change
- +19,225,760
- Value change
- +$47,445,492
- Number of holders
- 99
- Shares outstanding
- 180,747,818
- SEC-reported price per share
- $1.93
- Insider filing price
- $1.93
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 15673T100.
- 99 institutions reported positions in Q2 2026.
- 9 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 72 to 99 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $312,461,788 to $386,982,337.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 99 institutions filings for Q2 2026.
Security key
15673T100
Latest holder period
Q2 2026
13F holders
99
13D/G owners
9
CIK / CUSIP context first
Open Q2 2026 holders
IPSC full holder history
Century Therapeutics, Inc. SEC filings
Century Therapeutics, Inc. company facts
Century Therapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 15673T100:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
9
Security
IPSC
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 9.9% | $16,997,172 | 17,944,649 | RA Capital Management, L.P. | 09 Jan 2026 | |||
| TCG Crossover GP II, LLC | 9.9% | $15,978,987 | 17,754,430 | Chen Yu | 09 Jan 2026 | |||
| Deep Track Capital, LP | 7.3% | $12,137,760 | 13,486,400 | Deep Track Capital, LP | 08 Jan 2026 | |||
| Venrock Healthcare Capital Partners III, L.P. | 7.1% | +48% | $12,354,782 | +$8,606,536 | 13,043,478 | +230% | Venrock Healthcare Capital Partners III, L.P. | 09 Jan 2026 |
| RTW INVESTMENTS, LP | 7.1% | $29,608,695 | 13,043,478 | RTW Investments, LP | 31 Mar 2026 | |||
| Commodore Capital LP | 7.1% | $12,354,782 | 13,043,478 | Commodore Capital LP | 09 Jan 2026 | |||
| Point72 Asset Management, L.P. | 3.3% | -50% | $13,539,819 | +$7,071 | 5,964,678 | +0.05% | Point72 Asset Management, L.P. | 31 Mar 2026 |
| Bain Capital Life Sciences Opportunities III, LP | 4.1% | $1,762,227 | 3,538,609 | Bain Capital Life Sciences Opportunities III, LP | 30 Sep 2025 | |||
| Casdin Capital, LLC | 3.7% | $1,702,527 | 3,212,316 | Casdin Capital, LLC | 31 Mar 2025 |
As of 30 Jun 2026, 99 institutional investors reported holding 158,001,283 shares of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC). This represents 87% of the company’s total 180,747,818 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
82%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| TCG Crossover Management, LLC | 9.8% | 17,754,430 | 0% | 1% | $43,401,690 |
| RA CAPITAL MANAGEMENT, L.P. | 9.8% | 17,754,430 | 0% | 0.38% | $43,498,354 |
| Versant Venture Management, LLC | 6.7% | 12,166,109 | 0% | 18% | $29,806,967 |
| Deep Track Capital, LP | 5.2% | 9,462,645 | -0.26% | 0.34% | $23,183,480 |
| Commodore Capital LP | 4.8% | 8,695,652 | 0% | 1.3% | $21,304,347 |
| RTW INVESTMENTS, LP | 4.8% | 8,695,652 | 0% | 0.18% | $21,304,347 |
| Venrock Adviser, LLC | 4.8% | 8,695,652 | 0% | 0.65% | $21,304,347 |
| BlackRock, Inc. | 4.5% | 8,091,768 | +431% | 0% | $19,824,831 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.2% | 5,703,680 | +0.31% | 0% | $13,974,016 |
| Balyasny Asset Management L.P. | 3.1% | 5,522,944 | +10% | 0.02% | $13,531,213 |
| Point72 Asset Management, L.P. | 2.8% | 4,980,526 | -16% | 0.02% | $12,202,289 |
| Seven Fleet Capital Management LP | 2.4% | 4,347,826 | +47% | 1.8% | $10,652,174 |
| Woodline Partners LP | 2.4% | 4,257,530 | +40% | 0.03% | $10,430,948 |
| MILLENNIUM MANAGEMENT LLC | 2.3% | 4,194,981 | -10% | 0.01% | $10,277,703 |
| Trails Edge Capital Partners, LP | 2.3% | 4,134,969 | +69% | 1.6% | $10,130,674 |
| Spruce Street Capital LP | 2.2% | 4,059,054 | 0% | 2% | $9,944,682 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.1% | 3,789,538 | 0% | 0.01% | $9,284,368 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.6% | 2,979,529 | +129% | 0% | $7,301,590 |
| TWO SIGMA INVESTMENTS, LP | 1.5% | 2,699,013 | +14% | 0% | $6,612,582 |
| DAFNA Capital Management LLC | 1.3% | 2,400,458 | -1.4% | 1.1% | $5,881,122 |
| STEMPOINT CAPITAL LP | 1.2% | 2,146,182 | 0.91% | $5,258,146 | |
| STATE STREET CORP | 1% | 1,843,154 | +377% | 0% | $4,515,727 |
| NORTHERN TRUST CORP | 0.88% | 1,593,944 | +591% | 0% | $3,905,163 |
| DV Trading LLC | 0.77% | 1,400,000 | 0% | 0.28% | $3,430,000 |
| Rock Springs Capital Management LP | 0.72% | 1,304,347 | 0% | 0.16% | $3,195,650 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
21
Latest
Q2 2026
Rows shown
1-21 of 21
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 158,001,283 | $386,982,337 | +$47,445,492 | $2.45 | 99 |
| 2026 Q1 | 138,751,378 | $312,461,788 | +$246,781,319 | $2.26 | 72 |
| 2025 Q4 | 25,712,702 | $25,569,840 | +$6,410,887 | $0.99 | 46 |
| 2025 Q3 | 20,280,322 | $10,103,490 | -$1,188,475 | $0.50 | 53 |
| 2025 Q2 | 22,628,192 | $12,642,486 | -$3,582,180 | $0.56 | 64 |
| 2025 Q1 | 29,565,044 | $14,071,235 | -$4,277,613 | $0.48 | 69 |
| 2024 Q4 | 36,396,514 | $36,761,199 | -$7,768,598 | $1.01 | 70 |
| 2024 Q3 | 39,649,193 | $67,797,499 | -$1,211,276 | $1.71 | 66 |
| 2024 Q2 | 40,117,934 | $102,301,880 | +$40,961,743 | $2.55 | 59 |
| 2024 Q1 | 23,113,173 | $96,605,177 | +$22,882,584 | $4.18 | 66 |
| 2023 Q4 | 17,675,436 | $58,683,678 | -$543,594 | $3.32 | 60 |
| 2023 Q3 | 18,060,757 | $36,118,983 | -$2,770,150 | $2.00 | 53 |
| 2023 Q2 | 19,290,007 | $60,957,915 | -$2,350,461 | $3.16 | 62 |
| 2023 Q1 | 20,016,851 | $69,456,630 | -$4,620,580 | $3.47 | 63 |
| 2022 Q4 | 20,893,156 | $107,178,277 | -$3,631,215 | $5.13 | 65 |
| 2022 Q3 | 21,098,040 | $208,661,435 | -$4,940,964 | $9.89 | 52 |
| 2022 Q2 | 21,756,667 | $182,752,181 | -$3,241,178 | $8.40 | 51 |
| 2022 Q1 | 22,151,698 | $278,859,136 | +$11,504,710 | $12.59 | 51 |
| 2021 Q4 | 21,137,514 | $335,200,000 | +$24,348,825 | $15.86 | 50 |
| 2021 Q3 | 19,798,633 | $496,205,288 | +$62,122,502 | $25.16 | 47 |
| 2021 Q2 | 16,881,896 | $490,834,435 | +$490,834,432 | $29.34 | 35 |